- Home
- CYBR vs WAT Comparison
CYBR vs WAT Comparison
Compare CYBR & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBR
- WAT
- Stock Information
- Founded
- CYBR 1999
- WAT 1958
- Country
- CYBR Israel
- WAT United States
- Employees
- CYBR N/A
- WAT N/A
- Industry
- CYBR Computer Software: Prepackaged Software
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- CYBR Technology
- WAT Industrials
- Exchange
- CYBR Nasdaq
- WAT Nasdaq
- Market Cap
- CYBR 19.7B
- WAT 20.1B
- IPO Year
- CYBR 2014
- WAT 1995
- Fundamental
- Price
- CYBR $383.05
- WAT $342.65
- Analyst Decision
- CYBR Strong Buy
- WAT Buy
- Analyst Count
- CYBR 33
- WAT 15
- Target Price
- CYBR $408.18
- WAT $387.60
- AVG Volume (30 Days)
- CYBR 673.7K
- WAT 424.4K
- Earning Date
- CYBR 08-07-2025
- WAT 07-30-2025
- Dividend Yield
- CYBR N/A
- WAT N/A
- EPS Growth
- CYBR N/A
- WAT 8.23
- EPS
- CYBR N/A
- WAT 11.02
- Revenue
- CYBR $1,096,793,000.00
- WAT $2,983,253,000.00
- Revenue This Year
- CYBR $34.80
- WAT $6.07
- Revenue Next Year
- CYBR $19.50
- WAT $6.44
- P/E Ratio
- CYBR N/A
- WAT $31.07
- Revenue Growth
- CYBR 35.12
- WAT 2.57
- 52 Week Low
- CYBR $230.00
- WAT $279.24
- 52 Week High
- CYBR $421.00
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- CYBR 51.62
- WAT 46.54
- Support Level
- CYBR $381.85
- WAT $334.00
- Resistance Level
- CYBR $397.98
- WAT $349.91
- Average True Range (ATR)
- CYBR 10.84
- WAT 8.05
- MACD
- CYBR -2.31
- WAT -1.13
- Stochastic Oscillator
- CYBR 5.94
- WAT 38.09
About CYBR CyberArk Software Ltd.
CyberArk is a cybersecurity vendor focused on the identity market. The company's core privileged access management offering is a market leader in that subsegment, with more than half of the Fortune 500 as CyberArk customers. The identity security vendor was founded in 1999 and has around 9,000 customers across various industries. While CyberArk historically sold its security solutions primarily via on-premises licenses, over the past few years it has transitioned to a subscription recurring-revenue model.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.